Zomedica Stock News

The downward momentum from last week's Q3 update continues.

It's a risky play no doubt, but ZOM stock stands to get out of its current rut as a key temporary issue subsides. The post Zomedica Is Languishing Today, but Keep an Eye on This Risky Play appeared fi

Ford Motor Company (F) with the stream of 0.05% also noticed, India Zomedica Corp. (ZOM) encountered a rapid change of -0.35% in the last hour of Tuesdays trading session. Ford The post Do Beta Hits Key Level? Ford Motor Company (NYSDo Beta Hits Key Level? Ford Motor Company (NYSE:F), Zomedica Corp. (AMEX:ZOM)E:F), Zomedica Corp. (AMEX:ZOM) appeared first on Stocks Equity .

Zomedica Corp. (AMEX:ZOM) price is hovering lower on Tuesday, November 16, dropping -0.52% below its previous close. >> 7 Top Picks for the Post-Pandemic Economy > 7 Top Picks for the Post-Pandemic Economy

Check these penny stocks out for your watchlist this week The post Are These Penny Stocks on Your Watchlist This Week? appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.

Check these penny stocks out for your watchlist this week The post Are These Penny Stocks on Your Watchlist This Week? appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.

Zomedica Corp. (NYSEAMERICAN:ZOM) shares gapped up before the market opened on Friday . The stock had previously closed at $0.51, but opened at $0.53. Zomedica shares last traded at $0.53, with a volume of 8,420 shares. The company has a market cap of $528.07 million, a price-to-earnings ratio of -8.98 and a beta of 0.47. []

While meme trends are on the wane, these seven penny stocks still stand to make turbocharged moves higher in the short-term. The post 7 Penny Stocks That Could Have an Explosive Year-End appeared firs

Sometimes the safest decision is to hold cash and wait for an opportunity.

ZOM stock had its best days in early 2021, but now its weak financial performance fully justifies its price weakness. The post Stay Away From Zomedica for These 3 Key Reasons appeared first on Investo

Zomedica's acquisition is precisely what was needed to get ZOM stock out of its lethargy. Long-term, it could be a game-changer.

While a C-suite scenery change might be good for Zomedica, the shift may not provide a similar outcome for ZOM stock. The post Zomedica Stock Will Need More Than a Change in Management to Bounce Back

A turnaround in ZOM stock may happen sooner rather than later as Zomedica undergoes an executive-level change and builds out its business. The post New CEO and Acquisition Could Breathe New Life Into

ZOM stock can be a pet care industry leader, but it needs to make significant improvements before becoming a solid long-term play. The post Zomedica Has Potential, but It's Far Too Expensive for Now a

The stock price of Zomedica Corp (NYSEAMERICAN: ZOM) increased by over 2% pre-market today. This is why it happened.